AI English summary of an SEC filing — figures as filed
Intuitive Surgical ISRGIntuitive Surgical said Q4 2024 revenue was approximately $2.41 billion, an increase of 25% compared with Q4 2023 $1.93 billion, and full-year 2024 revenue was approximately $8.35 billion, an increase of 17% compared with 2023 $7.12 billion. These figures are unaudited preliminary results and are subject to adjustment.
Key points
AI summaryIntuitive Surgical said Q4 2024 revenue was approximately $2.41 billion, an increase of 25% compared with Q4 2023 $1.93 billion, and full-year 2024 revenue was approximately $8.35 billion, an increase of 17% compared with 2023 $7.12 billion. These figures are unaudited preliminary results and are subject to adjustment.
Intuitive Surgical said 2024 da Vinci procedures totaled approximately 2,683,000, an increase of approximately 17% compared with approximately 2,286,000 in 2023. The company also said it expects worldwide da Vinci procedures to increase approximately 13% to 16% in 2025.
Intuitive Surgical said it placed 493 da Vinci surgical systems, of which 5 were da Vinci 174 systems, in Q4 2024, an increase of 19% compared with 415 in Q4 2023. For full-year 2024, the company placed 1,526 da Vinci surgical systems, of which 5 were da Vinci 362 systems, an increase of 11% compared with 1,370 in 2023.
Intuitive Surgical said Q4 2024 instruments and accessories revenue increased by 23% to approximately $1.41 billion, and systems revenue increased by 36% to approximately $655 million. The company said the increase in systems revenue reflected in part a lower mix of leased systems relative to previous periods as well as higher da Vinci system average selling prices.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Q4 2024 and Full-Year Preliminary Revenue
Intuitive Surgical said Q4 2024 revenue was approximately $2.41 billion, an increase of 25% compared with Q4 2023 $1.93 billion, and full-year 2024 revenue was approximately $8.35 billion, an increase of 17% compared with 2023 $7.12 billion. These figures are unaudited preliminary results and are subject to adjustment.
Source · Based on the filing body and exhibits
da Vinci Procedure Volume and 2025 Outlook
Intuitive Surgical said 2024 da Vinci procedures totaled approximately 2,683,000, an increase of approximately 17% compared with approximately 2,286,000 in 2023. The company also said it expects worldwide da Vinci procedures to increase approximately 13% to 16% in 2025.
Source · Based on the filing body and exhibits
da Vinci System Placements
Intuitive Surgical said it placed 493 da Vinci surgical systems, of which 5 were da Vinci 174 systems, in Q4 2024, an increase of 19% compared with 415 in Q4 2023. For full-year 2024, the company placed 1,526 da Vinci surgical systems, of which 5 were da Vinci 362 systems, an increase of 11% compared with 1,370 in 2023.
Source · Based on the filing body and exhibits
Q4 2024 Instruments and Accessories and Systems Revenue
Intuitive Surgical said Q4 2024 instruments and accessories revenue increased by 23% to approximately $1.41 billion, and systems revenue increased by 36% to approximately $655 million. The company said the increase in systems revenue reflected in part a lower mix of leased systems relative to previous periods as well as higher da Vinci system average selling prices.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…